KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Total Non-Current Liabilities (2016 - 2026)

Regeneron Pharmaceuticals (REGN) has disclosed Total Non-Current Liabilities for 18 consecutive years, with $7.3 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Non-Current Liabilities rose 12.89% year-over-year to $7.3 billion; the TTM value through Mar 2026 reached $7.3 billion, up 12.89%, while the annual FY2025 figure was $7.3 billion, 6.56% up from the prior year.
  • Total Non-Current Liabilities hit $7.3 billion in Q1 2026 for Regeneron Pharmaceuticals, roughly flat from $7.3 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $7.3 billion in Q3 2025 and bottomed at $5.6 billion in Q3 2022.
  • Average Total Non-Current Liabilities over 5 years is $6.5 billion, with a median of $6.5 billion recorded in 2024.
  • Year-over-year, Total Non-Current Liabilities grew 27.92% in 2023 and then fell 8.91% in 2024.
  • Regeneron Pharmaceuticals' Total Non-Current Liabilities stood at $5.9 billion in 2022, then rose by 5.76% to $6.3 billion in 2023, then rose by 9.3% to $6.8 billion in 2024, then rose by 6.56% to $7.3 billion in 2025, then increased by 0.49% to $7.3 billion in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $7.3 billion, $7.3 billion, and $7.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.